Related Experiment Videos

Protein-losing enteropathy after Fontan operation for tricuspid atresia (imperforate tricuspid valve)

Insights

Protein-losing enteropathy resolved in a child after Fontan surgery by adding a bioprosthetic valve. This suggests valved conduits may improve outcomes for complex congenital heart disease patients.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Surgery
  • Gastroenterology

Background:

  • The Fontan operation is a palliative procedure for complex single-ventricle congenital heart defects.
  • Protein-losing enteropathy (PLE) is a serious complication following Fontan surgery.
  • Atrioventricular (AV) type Fontan repair with a valveless conduit can lead to complications.

Observation:

  • A 7-year-old girl with tricuspid atresia and a hypoplastic right ventricle developed PLE one year post-Fontan.
  • Recatheterization revealed severe conduit regurgitation and right ventricular enlargement.
  • The patient underwent successful insertion of a bioprosthetic valve at the right atrial appendage.

Findings:

  • The bioprosthetic valve insertion resulted in dramatic clinical improvement and resolution of PLE.
  • This suggests that conduit function and right ventricular status are critical in managing post-Fontan complications.
  • Severe conduit regurgitation was a key factor contributing to PLE in this case.

Implications:

  • The use of a valved conduit is recommended for AV type Fontan repair in specific patient profiles.
  • This approach may prevent or mitigate complications like PLE and conduit regurgitation.
  • Optimizing Fontan physiology through surgical modifications can significantly improve long-term outcomes in pediatric cardiac patients.

Related Concept Videos